Cancer diagnostics in Germany is a set of high-tech examinations that detect cancer at an early stage, when treatment is most effective, and determine its exact type and extent. German cancer centres use PET-CT, 3-Tesla MRI, image-guided biopsy and molecular tumour analysis; certified centres work according to national guidelines and discuss every case in a tumour board.

Cancer is the second most common cause of death worldwide, yet many cancers are curable when detected early:
Regular screening finds a tumour before symptoms appear, when it is small and has not spread.
PET-CT combines positron emission tomography with computed tomography and is one of the most informative methods in oncology. It makes it possible to:
Before the scan the patient receives a radiotracer, most often 18F-FDG, which accumulates in tumour cells with increased metabolism; the whole-body scan follows after about 60 minutes. For prostate cancer, PSMA-PET-CT is used, and for neuroendocrine tumours DOTATATE-PET-CT.
A biopsy – taking a tissue sample for microscopic examination – is the decisive step: only the histological report confirms or rules out cancer.
German laboratories also perform immunohistochemistry (tumour receptors, e.g. hormone receptors and HER2) and molecular profiling to select targeted therapy and immunotherapy.
Tumour markers are proteins produced by tumour cells or by the body in response to cancer. They are mainly used to monitor treatment and detect recurrence. Tumour markers are not suitable for screening healthy people: a normal value does not rule out cancer, and an elevated value is often caused by benign conditions. The exception is PSA for prostate cancer, which is measured after an informed discussion with the doctor.
| Marker | Tumour type |
|---|---|
| PSA | prostate cancer |
| CA 125 | ovarian cancer |
| CA 19-9 | pancreatic and gastrointestinal cancer |
| CEA | colorectal and lung cancer |
| AFP | liver cancer, germ cell tumours |
| CA 15-3 | breast cancer |
In Germany, statutory early-detection programmes start at fixed ages: skin cancer screening from 35, cervical cancer screening from 20, colorectal cancer screening from 50, prostate examination for men from 45 and mammography screening for women aged 50 to 75. Private clinics offer extended programmes:
Mammography, breast ultrasound and a consultation; women with BRCA mutations additionally receive breast MRI.
PSA test after informed discussion, examination and, if indicated, prostate MRI and MRI/ultrasound fusion biopsy.
Colonoscopy or a stool test for occult blood, gastroscopy if indicated; recommended from age 50, earlier if relatives have had colorectal cancer.
Low-dose CT of the chest for long-term heavy smokers aged 50 to 75 after consultation with a pulmonologist.
Cancer diagnostics in Germany costs from about 300 € for an oncologist consultation to 3,500 € and more for a comprehensive screening programme; a whole-body PET-CT costs from 2,500 €. The final price depends on the examinations the doctor considers necessary.
| Examination | Cost |
|---|---|
| Oncologist consultation | from 300 € |
| Tumour marker panel | from 250 € |
| Whole-body PET-CT | from 2,500 € |
| MRI (one region) | from 800 € |
| Ultrasound/CT-guided biopsy | from 1,500 € |
| Histology + immunohistochemistry | from 600 € |
| Molecular profiling | from 3,000 € |
| Comprehensive cancer screening | from 3,500 € |
Or send us a message:
